PMD knows the sweat patch is gaining market share versus urine and saliva.
They also know that once social distancing becomes a thing of the past, that PCHM will hold on to at least some of those markets share gains that resulted from social distancing.
I'm not as optimistic that PMD's fundamentals improve.
PMD has always been a player in Fortune 500 drug testing. I think that corporate drug testing in general may decrease as marijuana becomes more acceptable in the mainstream and that corporations test less as more people permanently work from home.
Are there social distancing opportunities for PCHM in the corporate drug testing world?
PCHM is on track for over $7 million in 2020 revenues, and possibly significantly higher.
I would like the company to update otcmarkets with how many employees the company currently has. Is it possible that they only have six employees still?
If so, second half operating margins should be higher. Even with taxes, our margins are very juicy.